CLINICAL TRIALS PROFILE FOR VON WILLEBRAND FACTOR (RECOMBINANT)
✉ Email this page to a colleague
All Clinical Trials for von willebrand factor (recombinant)
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00004357 ↗ | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 2 | 1997-09-01 | Juvenile dermatomyositis (JDM) is a connective tissue disease that causes skin rash and weak muscles in children. The purpose of this study is to measure the absorption of oral prednisolone and intravenous (IV) methylprednisolone and to determine levels of disease activity indicators in the blood. These levels will be compared to see if there are patterns specific to active and less active JDM. |
NCT00004357 ↗ | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis | Completed | Northwestern University | Phase 2 | 1997-09-01 | Juvenile dermatomyositis (JDM) is a connective tissue disease that causes skin rash and weak muscles in children. The purpose of this study is to measure the absorption of oral prednisolone and intravenous (IV) methylprednisolone and to determine levels of disease activity indicators in the blood. These levels will be compared to see if there are patterns specific to active and less active JDM. |
NCT00004360 ↗ | Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus | Completed | Northwestern University | 1995-09-01 | OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus. | |
NCT00004360 ↗ | Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus | Completed | National Center for Research Resources (NCRR) | 1995-09-01 | OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus. | |
NCT00004667 ↗ | Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease | Completed | University of North Carolina | Phase 1 | 1993-10-01 | OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding time, in vivo recovery, and circulating half-life of the infused factor in patients with von Willebrand's disease. II. Assess the safety of von Willebrand factor in these patients. |
NCT00004667 ↗ | Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease | Completed | National Center for Research Resources (NCRR) | Phase 1 | 1993-10-01 | OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding time, in vivo recovery, and circulating half-life of the infused factor in patients with von Willebrand's disease. II. Assess the safety of von Willebrand factor in these patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for von willebrand factor (recombinant)
Condition Name
Clinical Trial Locations for von willebrand factor (recombinant)
Trials by Country
Clinical Trial Progress for von willebrand factor (recombinant)
Clinical Trial Phase
Clinical Trial Sponsors for von willebrand factor (recombinant)
Sponsor Name